Terns, Inc.
🏢 View company profile →8Patents
8Active
8Granted
46Portfolio score
Filing activity: Apr 12, 2019 → Feb 13, 2025
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10800767B2 | Thyroid hormone receptor beta agonist compounds | Human Necessities | 8 | Active |
| US11034676B2 | THRB receptor agonist compound and preparation method and use thereof | Human Necessities | 5 | Active |
| US11084802B2 | THRβ receptor agonist compound and preparation method and use thereof | Human Necessities | 5 | Active |
| US11203587B2 | Thyroid hormone receptor beta agonist compounds | Chemistry; Metallurgy | 3 | Active |
| US10889571B2 | Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias | Chemistry; Metallurgy | 1 | Active |
| US12338232B2 | THRβ receptor agonist compound and preparation method and use thereof | Human Necessities | 0 | Active |
| US12365669B2 | THRβ receptor agonist compound and preparation method and use thereof | Human Necessities | 0 | Active |
| US10919911B2 | Tricyclic ASK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.